High disability early in RA tied to increased mortality risk, finds study Medha Baranwal12 Sept 2020 8:22 AM ISTCanada: Higher self-reported disability and disease activity score (DAS) at 1 year significantly increased all‐cause mortality in...
Early DMARD therapy for rheumatoid arthritis lowers CVD risk: BMJ Medha Baranwal4 Sept 2020 6:00 PM ISTUK: Cardiovascular abnormalities are present in early rheumatoid arthritis (ERA) which can be improved using disease-modifying antirheumatic...
Lupin launches rheumatoid arthritis drug Leflunomide in US Ruchika Sharma3 Sept 2020 11:58 AM ISTMumbai, Baltimore: Drugmaker Lupin Limited has announced the launch of Leflunomide Tablets USP, 10 mg and 20 mg, having received an approval from the...
Cadila Pharma launches arthritis biosimilar drug Cadalimab in India Ruchika Sharma29 Aug 2020 2:09 PM ISTCadalimab has shown to have significant reduction in signs and symptoms of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing...
Dr Reddys launches generic version of Cuprimine Capsules in US Ruchika Sharma28 Aug 2020 11:39 AM ISTPenicillamine USP is a chelating agent used in the treatment of Wilson's disease.
Lupin, Mylan launch arthritis drug Nepexto in Germany Ruchika Sharma27 Aug 2020 11:53 AM ISTThe product is available as an injectable in an easy-to-use pre- filled pen and a pre-filled syringe.
Continuing versus tapering steroids after achieving remission in RA, finds Lancet study Hina Zahid21 Aug 2020 9:30 PM ISTIs the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early...
Rheumatoid arthritis patients at lower risk of type 2 diabetes: Study Dr. Kamal Kant Kohli5 Aug 2020 9:42 PM ISTWILEY - Researchers have found in a recent analysis of a US commercial insurance database that adults with rheumatoid arthritis had a lower risk...
Upadacitinib may alone improve treatment outcomes in rheumatoid Arthritis: Study Dr.Niharika Harsha B31 July 2020 8:57 PM ISTMonotherapy with Upadacitinib demonstrated significant improvements in clinical, radiographic, and patient‐reported outcomes in patients with...
Cadila pharma unveils biosimilar Rituximab under brand name Ritucad Ruchika Sharma30 July 2020 1:01 PM ISTRitucad is used in the treatment of Non-Hodgkin's lymphoma( a type of blood-related cancer)
Tocilizumab increases risk of GI perforation in rheumatoid arthritis: BMJ Medha Baranwal26 July 2020 8:59 PM ISTSweden: Tocilizumab (Actemra) treatment versus TNF inhibitors in patients with rheumatoid arthritis (RA) doubles the risk of gastrointestinal...
Newly discovered PRIME cells may predict rheumatoid arthritis flares: NEJM Study Dr. Kamal Kant Kohli17 July 2020 6:00 PM ISTRheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). During symptoms flare up,...
